Mizuho lowered the firm’s price target on Teladoc (TDOC) to $6 from $10 and keeps a Neutral rating on the shares. The company ended 2025 with a second consecutive year of declines in both revenue and EBITDA, the analyst tells investors in a research note. The firm says Teladoc’s 2026 guidance came in slightly below Street consensus at the midpoints for both revenue and EBITDA.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC: